chr5-38527188-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001127671.2(LIFR):āc.364A>Gā(p.Thr122Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,593,666 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T122T) has been classified as Likely benign.
Frequency
Consequence
NM_001127671.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIFR | NM_001127671.2 | c.364A>G | p.Thr122Ala | missense_variant | 4/20 | ENST00000453190.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIFR | ENST00000453190.7 | c.364A>G | p.Thr122Ala | missense_variant | 4/20 | 2 | NM_001127671.2 | P1 | |
LIFR | ENST00000263409.8 | c.364A>G | p.Thr122Ala | missense_variant | 4/20 | 1 | P1 | ||
LIFR | ENST00000503088.1 | n.527A>G | non_coding_transcript_exon_variant | 4/15 | 1 | ||||
LIFR | ENST00000506990.5 | c.364A>G | p.Thr122Ala | missense_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00122 AC: 186AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000256 AC: 63AN: 246530Hom.: 0 AF XY: 0.000165 AC XY: 22AN XY: 133214
GnomAD4 exome AF: 0.000112 AC: 162AN: 1441306Hom.: 1 Cov.: 27 AF XY: 0.0000919 AC XY: 66AN XY: 717958
GnomAD4 genome AF: 0.00123 AC: 187AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.00114 AC XY: 85AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 12, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Stuve-Wiedemann syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 08, 2019 | The LIFR c.364A>G; p.Thr122Ala variant (rs145163157), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 283380). This variant is found in the African population with an allele frequency of 0.35% (86/24,768 alleles) in the Genome Aggregation Database. The threonine at codon 122 is weakly conserved, and computational algorithms (PolyPhen-2, SIFT) predict that this variant is benign. However, due to limited information, the clinical significance of this variant is uncertain at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at